Skip to main content

Aldevron North Production

Aldevron is one of the world’s largest manufacturers of Plasmid DNA, mRNA, proteins and other high-quality biologics that support the bio pharmaceutical industry. The demand for Aldevron’s services was already rising when work began on the campus expansion and the rise of COVID-19 expedited the timeline for the project’s completion and called for more specialized manufacturing spaces and operational capacity to quickly help alleviate the stress on vaccination producers.

With short timelines and a high need for workable spaces, the project team had to be fluid in their approach and highly efficient. Throughout, much of construction work had to be redirected while manufacturing and mechanical plans were revised to meet the everchanging demands and expectations of production throughout the building.

The project scope included the renovation of a 45,000 sf building into a state-of-the-art biopharmaceutical research-grade and process development facility and a 189,000 sf expansion with the space and infrastructure to support the company’s growth and demand for years to come.

Additions include production spaces, clean rooms, interstitial mechanical space, centralized waste facilities, 14,000 sf of high-bay warehouse storage and workspace for up to 620 employees.

Project Overview


Owner
Aldevron LLC
Go to Aldevron LLC
Location
Fargo, ND
Completion
March 2021

Project Details


Delivery Method
Construction Management at Risk
Total Square Feet
234,000
GCS Project Team
Architecture Firm
Zerr Berg Architects